Therapeutic Area Market Research Reports & Industry Analysis

The Therapeutic Area Market refers to a specific category of diseases or conditions for which there are known medical treatments or promising treatments in development. It is a way to classify drugs without reference to the type of therapy, form of action, or the company that makes it, but instead to look at the disease it treats.

Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.

Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.

...Show More ...Show Less


Therapeutic Area Industry Research & Market Reports

  • Orthopedic Navigation Systems

    ... at a CAGR of 15.0% over the analysis period 2024-2030. Electromagnetic, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach US$286.9 Million by the end of the ... Read More

  • Pedicle Screw System

    ... at a CAGR of 4.0% over the analysis period 2024-2030. Polyaxial, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.6 Billion by the end of the ... Read More

  • Orthopedic Medical Imaging Systems

    ... 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. X-ray Systems, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$4.1 Billion by the ... Read More

  • Vitreous Tamponades

    ... CAGR of 3.0% over the analysis period 2024-2030. Gaseous Tamponades, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$50.9 Million by the end of the analysis ... Read More

  • Respiratory Inhalers

    ... CAGR of 6.0% over the analysis period 2024-2030. Manual, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$54.4 Billion by the end of the analysis period. ... Read More

  • Retinal Laser Equipment

    ... at a CAGR of 7.1% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$693.0 Million by the end of the ... Read More

  • Knee Braces

    ... CAGR of 5.2% over the analysis period 2024-2030. Functional, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$875.4 Million by the end of the analysis period. ... Read More

  • Home Pregnancy Tests (HPT)

    ... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Digital Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$597.6 Million by the ... Read More

  • Artificial Tendons and Ligaments

    ... 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Knee Injuries, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$35.2 Million by the ... Read More

  • Cardiovascular Repair and Reconstruction Devices

    ... Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cardiovascular Grafts, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$4.3 Billion ... Read More

  • Allergy Treatment

    ... CAGR of 3.7% over the analysis period 2024-2030. Asthma, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$5.9 Billion by the end of the analysis period. ... Read More

  • Botulinum Toxin

    ... CAGR of 8.8% over the analysis period 2024-2030. Type A, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$11.0 Billion by the end of the analysis ... Read More

  • Lung Cancer Therapeutics

    ... at a CAGR of 10.8% over the analysis period 2024-2030. Non-Small-Cell Lung Cancer (NSCLC), one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach US$82.3 Billion by the ... Read More

  • Orthopedic Devices

    ... CAGR of 6.5% over the analysis period 2024-2030. Joint Reconstruction, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$44.6 Billion by the end of the analysis ... Read More

  • EEG, EMG and Evoked Potential Devices

    ... reach US$1.7 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Electroencephalograph Equipment, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach ... Read More

  • Respiratory Care Devices

    ... at a CAGR of 5.8% over the analysis period 2024-2030. Therapeutic Devices, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$15.7 Billion by the end of ... Read More

  • Cancer Cachexia Global Market Report 2025

    ... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More

  • Prostate Cancer Nuclear Medicine Diagnostics Global Market Report 2025

    ... cancer nuclear medicine diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More

  • Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases

    ... expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 8.3% CAGR ... Read More

  • Nicotine Gum

    ... CAGR of 4.8% over the analysis period 2024-2030. 2 mg, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$5.0 Billion by the end of the analysis ... Read More

  • Non-Melanoma Skin Cancer

    ... at a CAGR of 4.4% over the analysis period 2024-2030. Basal Cell Carcinoma (BCC), one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$835.6 Million by the ... Read More

  • Online Sex Toys

    ... at a CAGR of 6.8% over the analysis period 2024-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$9.5 Billion by the end of ... Read More

  • Pneumonia Therapeutics

    ... CAGR of 6.7% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of the analysis period. ... Read More

  • Radiology Information Systems

    ... at a CAGR of 7.4% over the analysis period 2024-2030. Integrated, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$1.3 Billion by the end of the ... Read More

  • Interventional Neurology Devices

    ... at a CAGR of 4.6% over the analysis period 2024-2030. Cerebral Embolization & Aneurysm Coiling, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.0 Billion by ... Read More

Cookie Settings